Public market insider buying at 48North Cannabis (NRTH)

Public market insider buying at 48North Cannabis (V:NRTH)

Pierre Caland, a 10% Holder, acquired 200,000 Common Shares on a control or direction basis for registered holder Wallington Investment Holdings Ltd. at prices ranging from $0.810 to $0.820 between July 9th and 10th, 2019. This represents a $163,000 investment into the company's shares and an account share holdings change of 1.1%.

48North Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

48North Cannabis Corp is a Canada-based company, which manufactures cannabis-based products for medical purposes. The Company's subsidiary, DelShen Therapeutics, is a licensed producer of medical cannabis in Canada. 48North Cannabis Corp grows genetics sourced from MariPharm BV, a Netherlands-based phytopharmaceutical company engaged in the research and cultivation of cannabis for medical purposes. DelShen Therapeutics is regulated by the Access to Cannabis for Medical Purposes Regulations (ACMPR) and the facility is located on an approximately 800-acres of owned land near Kirkland Lake, Ontario, Canada. DelShen Therapeutics operates in an approximately 40,000-square-foot closed-box facility, which produces more than 2,000 kilograms of cannabis annually.